Projects In Knowledge - Continuing Medical Education (CME)

Latest Programs

Expert Insight Into: Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer (Series Part 1)

Dr. Langer
Co-Chair

Oncology Article Review - EGFR gene mutations can produce hypersensitivity to EGFR tyrosine kinase inhibitors in patients with NSCLC, but studies investigating the clinical benefit of this approach in these patients have been lacking. Dr. Corey Langer comments on the findings from a prospective, large-scale study of erlotinib in NSCLC patients with EGFR mutations. more »1

Expert Insight Into: Physical Activity and Male Colorectal Cancer Survival

Dr. Eng
Faculty

Oncology Article Review - Although the protective effects of physical activity on the development of colorectal cancer are well recognized, data on the role of physical activity on outcomes in patients diagnosed with colorectal cancer are limited. In this course, Dr. Cathy Eng reviews the findings of a study that assessed the effects of post-diagnosis leisure-time physical activity on mortality in patients diagnosed with nonmetastatic colorectal cancer. more »2

Management of the Postfracture Patient

Dr. Lambing
Contributing Editor

Osteoporosis Chapter - Join Dr. Cheryl L. Lambing for Chapter 5 of the Osteoporosis Living Medical Textbook™ as she outlines postfracture management for patients with osteoporosis-related fractures. Whether of the wrist, hip, or spine, all fractures represent an increased risk for disability and future fracture. Know the steps of the recovery process for your patients with fractures: acute treatment, medical evaluation, and rehabilitation. more »3

Case Study: Incurable Metastatic Colorectal Cancer

Dr. Saltz
Chair

Oncology Tx Reporter e-Newsletter - In this newsletter, Dr. Leonard Saltz presents the case of a 57-year-old man with synchronous metastatic rectal cancer to illustrate the decision-making process with regard to management of the primary tumor and choice of systemic therapies for both first- and second-line treatment of metastatic disease. Dr. Saltz also describes all of the available options and reviews the related data from recent clinical trials. more »4

Expert Insight Into: High Risk of Recurrence for Breast Cancer Patients with HER2-Positive, Node-Negative Tumors 1 cm. or Smaller

Dr. Gonzalez-Angulo
Faculty

Oncology Article Review - Studies examining monoclonal antibody therapy against human epidermal growth factor receptor 2 (HER2) have excluded patients with node-negative tumors smaller than 1 cm. Dr. Ana Maria Gonzalez-Angulo and colleagues recently evaluated risk of recurrence in patients with small node-negative HER2-positive tumors. In this course, Dr. Gonzalez-Angulo comments on the findings and their implications for future clinical trials. more »5

Expert Insight Into: Immunomodulatory Effects of Vitamin D in Multiple Sclerosis

Dr. Dhib-Jalbut
Faculty

Neurology Article Review - Exposure to sunlight and vitamin D ingestion reduce the risk for MS. In this course, Dr. Suhayl Dhib-Jalbut comments on a study that showed significantly reduced serum 25 (OH) vitamin D and 1,25 (OH)₂ vitamin D levels in patients with relapsing-remitting MS, particularly during exacerbation, compared with healthy control subjects and patients with primary progressive MS. more »6

Expert Insight Into: Efficacy and Safety of Balloon Kyphoplasty Compared with Nonsurgical Care for Vertebral Compression Fracture: A Randomized Controlled Trial

Dr. Lambing
Faculty

Osteoporosis Article Review - Most patients with painful vertebral compression fractures forego the risks of conventional open surgical repair and receive supportive care during an extensive recovery period. Balloon kyphoplasty was developed as a minimally invasive treatment for compression vertebral fractures. Dr. Cheryl L. Lambing reviews findings from a randomized trial that compared the efficacy and safety of balloon kyphoplasty and nonsurgical care for improving the quality of life of patients with acute painful vertebral compression fractures. more »7

Case Study: Suboptimal Response to Treatment for Relapsing-Remitting Multiple Sclerosis

Dr. Lublin and Dr. Lisak
Chair and Faculty

Neurology Tx Reporter e-Newsletter - To illustrate when to switch from one disease-modifying therapy for MS to another, Dr. Robert P. Lisak presents the case of a 37-year-old man who experiences multiple relapses while on treatment. Dr. Lisak explores issues such as nonadherence, the clinical significance of radiologic changes, the utility of neutralizing antibody testing, the time necessary to reach maximal treatment response, and choice of second-line therapy. more »8

Expert Insight Into: Preoperative Radiotherapy Versus Selective Postoperative Chemoradiotherapy in Patients with Rectal Cancer (MRC CR07 and NCIC-CTG C016): A Multicentre, Randomised Trial

Dr. Sigurdson
Faculty

Oncology Article Review - On average, patients with rectal cancer who experience a local or regional recurrence fare quite poorly and can be expected to live no longer than 18 months. A recent clinical trial compared a short course of preoperative radiotherapy with selective postoperative chemoradiotherapy. Join Dr. Elin R. Sigurdson as she discusses the results, and learn which approach was preferred. more »9

Multidisciplinary Hepatocellular Carcinoma Virtual Tumor Board Discussion #2

Dr. Geschwind
Co-Chair

Oncology Podcast Series - Join Dr. Mary F. Mulcahy, a medical oncologist, as she leads a multidisciplinary team discussion on the management of advanced hepatocellular carcinoma. With her on the team are Dr. Jean Francois H. Geschwind, an interventional radiologist; Dr. Robert G. Gish, a hepatologist; and Dr. Alan W. Hemming, a surgeon. This course is part of The Advanced Certificate Program in Hepatocellular Carcinoma. more »10

Browse Home » Gastroenterology » Hematology » Infectious Diseases » Neurology » Oncology » Osteoporosis » Psychiatry » Women's Health » Keep up to date with us via twitter! Latest News powered by:	Latest Programs Expert Insight Into: Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer (Series Part 1) Dr. Langer Co-Chair Oncology Article Review - EGFR gene mutations can produce hypersensitivity to EGFR tyrosine kinase inhibitors in patients with NSCLC, but studies investigating the clinical benefit of this approach in these patients have been lacking. Dr. Corey Langer comments on the findings from a prospective, large-scale study of erlotinib in NSCLC patients with EGFR mutations. more »1 Expert Insight Into: Physical Activity and Male Colorectal Cancer Survival Dr. Eng Faculty Oncology Article Review - Although the protective effects of physical activity on the development of colorectal cancer are well recognized, data on the role of physical activity on outcomes in patients diagnosed with colorectal cancer are limited. In this course, Dr. Cathy Eng reviews the findings of a study that assessed the effects of post-diagnosis leisure-time physical activity on mortality in patients diagnosed with nonmetastatic colorectal cancer. more »2 Management of the Postfracture Patient Dr. Lambing Contributing Editor Osteoporosis Chapter - Join Dr. Cheryl L. Lambing for Chapter 5 of the Osteoporosis Living Medical Textbook™ as she outlines postfracture management for patients with osteoporosis-related fractures. Whether of the wrist, hip, or spine, all fractures represent an increased risk for disability and future fracture. Know the steps of the recovery process for your patients with fractures: acute treatment, medical evaluation, and rehabilitation. more »3 Case Study: Incurable Metastatic Colorectal Cancer Dr. Saltz Chair Oncology Tx Reporter e-Newsletter - In this newsletter, Dr. Leonard Saltz presents the case of a 57-year-old man with synchronous metastatic rectal cancer to illustrate the decision-making process with regard to management of the primary tumor and choice of systemic therapies for both first- and second-line treatment of metastatic disease. Dr. Saltz also describes all of the available options and reviews the related data from recent clinical trials. more »4 Expert Insight Into: High Risk of Recurrence for Breast Cancer Patients with HER2-Positive, Node-Negative Tumors 1 cm. or Smaller Dr. Gonzalez-Angulo Faculty Oncology Article Review - Studies examining monoclonal antibody therapy against human epidermal growth factor receptor 2 (HER2) have excluded patients with node-negative tumors smaller than 1 cm. Dr. Ana Maria Gonzalez-Angulo and colleagues recently evaluated risk of recurrence in patients with small node-negative HER2-positive tumors. In this course, Dr. Gonzalez-Angulo comments on the findings and their implications for future clinical trials. more »5 Expert Insight Into: Immunomodulatory Effects of Vitamin D in Multiple Sclerosis Dr. Dhib-Jalbut Faculty Neurology Article Review - Exposure to sunlight and vitamin D ingestion reduce the risk for MS. In this course, Dr. Suhayl Dhib-Jalbut comments on a study that showed significantly reduced serum 25 (OH) vitamin D and 1,25 (OH)₂ vitamin D levels in patients with relapsing-remitting MS, particularly during exacerbation, compared with healthy control subjects and patients with primary progressive MS. more »6 Expert Insight Into: Efficacy and Safety of Balloon Kyphoplasty Compared with Nonsurgical Care for Vertebral Compression Fracture: A Randomized Controlled Trial Dr. Lambing Faculty Osteoporosis Article Review - Most patients with painful vertebral compression fractures forego the risks of conventional open surgical repair and receive supportive care during an extensive recovery period. Balloon kyphoplasty was developed as a minimally invasive treatment for compression vertebral fractures. Dr. Cheryl L. Lambing reviews findings from a randomized trial that compared the efficacy and safety of balloon kyphoplasty and nonsurgical care for improving the quality of life of patients with acute painful vertebral compression fractures. more »7 Case Study: Suboptimal Response to Treatment for Relapsing-Remitting Multiple Sclerosis Dr. Lublin and Dr. Lisak Chair and Faculty Neurology Tx Reporter e-Newsletter - To illustrate when to switch from one disease-modifying therapy for MS to another, Dr. Robert P. Lisak presents the case of a 37-year-old man who experiences multiple relapses while on treatment. Dr. Lisak explores issues such as nonadherence, the clinical significance of radiologic changes, the utility of neutralizing antibody testing, the time necessary to reach maximal treatment response, and choice of second-line therapy. more »8 Expert Insight Into: Preoperative Radiotherapy Versus Selective Postoperative Chemoradiotherapy in Patients with Rectal Cancer (MRC CR07 and NCIC-CTG C016): A Multicentre, Randomised Trial Dr. Sigurdson Faculty Oncology Article Review - On average, patients with rectal cancer who experience a local or regional recurrence fare quite poorly and can be expected to live no longer than 18 months. A recent clinical trial compared a short course of preoperative radiotherapy with selective postoperative chemoradiotherapy. Join Dr. Elin R. Sigurdson as she discusses the results, and learn which approach was preferred. more »9 Multidisciplinary Hepatocellular Carcinoma Virtual Tumor Board Discussion #2 Dr. Geschwind Co-Chair Oncology Podcast Series - Join Dr. Mary F. Mulcahy, a medical oncologist, as she leads a multidisciplinary team discussion on the management of advanced hepatocellular carcinoma. With her on the team are Dr. Jean Francois H. Geschwind, an interventional radiologist; Dr. Robert G. Gish, a hepatologist; and Dr. Alan W. Hemming, a surgeon. This course is part of The Advanced Certificate Program in Hepatocellular Carcinoma. more »10	Featured Programs Lung Cancer Management III Osteoporosis: A Focus on Fracture Prevention On-Demand Webcast, Available 24/7 Watch It Now Game Changers in Hepatology— Future Challenges in the Treatment of HCV Projects In Knowledge poster presented at 2009 Breast Cancer Symposium Survey Findings: Breast Cancer Management by Nurses *Read more...* Update on Osteoporosis for the Rheumatologist On-Demand Webcast Zeroing in on Non-Small Cell Lung Cancer: Integrating Targeted Therapies into Practice On-Demand Webcast The Advanced Certificate Program: Multiple Sclerosis Management I & II Breast Cancer Management II Management of Stage III, N2 NSCLC: Virtual Thoracic Oncology Tumor Board Go to Activity Profiles in CML: Case-Based Approaches to Managing Resistance and Improving Outcomes *Webcast* Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities The Advanced Certificate Program: Lung Cancer Management II Living Medical Textbook Oncology Women's Cancers Edition	Living Medical Textbook Multiple Sclerosis Edition Experts Responding to Your Questions: Video Q&A *A Quarterly Online CME/CE activity* Insights into Managing Leukemia Edition The Advanced Certificate Program Hepatocellular Carcinoma Special Announcement Projects In Knowledge poster presented at DDW 2009 Survey Findings: HBV Management Among U.S. Clinicians *Read more...* The Certificate Program in Advanced/Metastatic Colorectal Cancer Living Medical Textbook Osteoporosis Fracture Prevention and Therapeutic Management Edition Osteoporosis Compendium Living Medical Textbook Oncology Tumor Immunology and Immunotherapy: Metastatic Melanoma Edition A Sea Change in MS Treatment— The Potential of Small Molecules On-Demand Interactive Webcast